MRK dividend yield: 3.25%. ENB dividend yield: 9.58%. Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s. Enbridge is Canada's largest energy infrastructure company, operating the world's longest crude oil and liquids transportation system. Its pipeline network moves ~30% of North American crude oil production. 29+ consecutive years of dividend growth. Long-term take-or-pay contracts provide cash flow visibility for years ahead.
Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Enbridge is Canada's largest energy infrastructure company, operating the world's longest crude oil and liquids transportation system. Its pipeline network moves ~30% of North American crude oil production. 29+ consecutive years of dividend growth. Long-term take-or-pay contracts provide cash flow visibility for years ahead.
MRK currently offers a 3.25% yield (3.08/share/year) while ENB offers 9.58% (3.66/share/year). ENB provides higher current income. However, MRK has grown its dividend faster (8.2% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in MRK vs ENB earn per year?
With $10,000 invested today: MRK pays approximately $325/year. ENB pays approximately $958/year. With DRIP reinvestment over 10 years, these grow to $950/year (MRK) and $4,487/year (ENB).
Does MRK or ENB pay monthly dividends?
MRK pays quarterly dividends. ENB pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this MRK vs ENB comparison by email
Save your analysis + get weekly dividend insights. Free forever.